1. Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
   Fabio Scianò et al, 2024, Future Medicinal Chemistry CrossRef
2. Establishment of a prognostic model for pancreatic cancer based on vesicle-mediated transport protein-related genes
   Yanfang Cao et al, 2024, Computer Methods in Biomechanics and Biomedical Engineering CrossRef
3. ZEB2 alleviates Hirschsprung’s-associated enterocolitis by promoting the proliferation and differentiation of enteric neural precursor cells via the Notch-1/Jagged-2 pathway
   Yong Feng et al, 2024, Gene CrossRef
4. HNF1A induces glioblastoma by upregulating EPS8 and activating PI3K/AKT signaling pathway
   Gang Yang et al, 2024, Biochemical Pharmacology CrossRef
5. Enhancing therapeutic efficacy in homologous recombination-proficient pancreatic cancer via the combination of PARP1-PROTAC and a BRD4 inhibitor
   Chunlan Pu et al, 2024, Bioorganic & Medicinal Chemistry CrossRef
6. High pyroptosis activity in pancreatic adenocarcinoma: poor prognosis and oxaliplatin resistance
   Guangfu Wang et al, 2024, Apoptosis CrossRef
7. KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping
   Jia Rao et al, 2024, The Journal of Pathology: Clinical Research CrossRef
8. Subtype-WGME enables whole-genome-wide multi-omics cancer subtyping
   Hai Yang et al, 2024, Cell Reports Methods CrossRef
9. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer
   Ling-bing Li et al, 2024, Acta Pharmacologica Sinica CrossRef